Christian Castaneda
Critical Care Medicine · Honolulu, HINPI 1609262435
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.1%), food and beverage and education — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by GSK at 52.1% of the total. 2025 is the largest year on record at $29,441, more than ten times the $70 reported in 2019. Among critical care medicine clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 217 payments — averaging $157.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$18K
- Intuitive Surgical$8K
- Olympus Corporation Of The Americas$2K
- Sanofi$2K
- Insmed, Inc.$1K
- Boehringer Ingelheim$762
- plus $2K from 13 others
What the payments were for
- Consulting fees$1,5815%
- Speaking & faculty fees$16,10047%
- Travel & lodging$4,31413%
- Food & beverage$6,46019%
- Education$5,69817%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 89 | $17,802 |
| Intuitive Surgical | 13 | $8,026 |
| Olympus Corporation Of The Americas | 6 | $2,049 |
| Sanofi | 5 | $1,809 |
| Insmed, Inc. | 56 | $1,436 |
| Boehringer Ingelheim | 10 | $762 |
| AstraZeneca | 15 | $725 |
| Mallinckrodt Hospital Products Inc. | 3 | $375 |
| Inari Medical, Inc. | 2 | $240 |
| Regeneron Healthcare Solutions, Inc. | 7 | $194 |
| Tactile Systems Technology Inc | 1 | $163 |
| Penumbra, Inc. | 1 | $147 |
| Pulmonx Corporation | 2 | $106 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| Boston Scientific | 1 | $85 |
| Pfizer | 1 | $70 |
| Bayer | 2 | $31 |
| Philips North America LLC | 1 | $20 |
| AbbVie | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUCALA$16,442
- Da Vinci Surgical System$7,910
- Spiration Valve System$1,960
- ACTHAR$375
- Arikayce$259
- TEZSPIRE$244
- OFEV$224
- TRELEGY ELLIPTA$214
- Flexitouch Plus$163
- Nimbl$163
- Indigo System$147
- FLOWTRIEVER CATHETER, S$145
- CT THROMBECTOMY SYSTEM KIT$145
- IMFINZI$125
- FASENRA$122
How this compares
$34,153 in reported general payments places this provider in the 95th percentile of 31 critical care medicine providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 156 | $120,006 |
| NucalaMepolizumab | 26 | $101,378 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 81 | $40,263 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 17 | $7,905 |
| Wixela InhubFluticasone Propion/Salmeterol | 24 | $2,313 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 63 | $1,583 |
| Omeprazole | 16 | $410 |
| Bupropion XlBupropion Hcl | 11 | $116 |
| Gabapentin | 12 | $96 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Nucala, Anoro Ellipta | $17,802 | $229,289199 claims |
| Boehringer IngelheimStiolto Respimat | $762 | $40,26381 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 31 critical care medicine providers in Hawaii.
Other critical care medicine in Honolulu
- Stephanie GuoHonolulu$9K
- Jordan LeeHonolulu$7K
- Brent TatsunoHonolulu$5K
- Learned GonzalesHonolulu$4K
- Chad TaoHonolulu$4K
- Benjamin BergHonolulu$3K
- Ronald SchaeferHonolulu$2K
- Nishal BrahmbhattHonolulu$2K
- Ryota SatoHonolulu$2K
- Timothy VosslerHonolulu$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.